ProclaRx is developing first-in-class anti-infectives both as combination devices and as biologics. The company has a growing product pipeline, with multiple candidates in development.

Platform 510(k) Submission Product
Combination Device    
Advanced Wound Care 2018 PCL-TSS
Platform IND-Enabling Phase 1 Phase 2/3 Product
Middle Ear Infections (CSOM) 2017 2018 2019 PCL-1440
Chronic Sinusitis (CVID) 2018 2019 2020 PCL-1550

Other Products in Development